Chemed Corporation $CHE Stock Holdings Lifted by SG Americas Securities LLC

SG Americas Securities LLC increased its holdings in Chemed Corporation (NYSE:CHE) by 65.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 3,030 shares of the company’s stock after buying an additional 1,195 shares during the period. SG Americas Securities LLC’s holdings in Chemed were worth $1,357,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of CHE. Creekmur Asset Management LLC acquired a new position in Chemed in the second quarter valued at approximately $28,000. Parkside Financial Bank & Trust lifted its holdings in shares of Chemed by 86.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after purchasing an additional 44 shares during the last quarter. HM Payson & Co. boosted its position in Chemed by 35.5% during the 3rd quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after purchasing an additional 27 shares during the period. Geneos Wealth Management Inc. grew its stake in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares during the last quarter. Finally, Mather Group LLC. bought a new position in Chemed during the 3rd quarter worth $65,000. Institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total value of $875,100.00. Following the completion of the sale, the chief executive officer directly owned 94,197 shares in the company, valued at $41,215,897.35. This represents a 2.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.29% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CHE. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Royal Bank Of Canada cut their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $574.25.

Chemed Stock Performance

Shares of CHE opened at $452.40 on Friday. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60. The stock’s fifty day moving average is $435.69 and its 200-day moving average is $444.32. The firm has a market capitalization of $6.41 billion, a price-to-earnings ratio of 23.92, a price-to-earnings-growth ratio of 2.24 and a beta of 0.44.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). Chemed had a net margin of 11.02% and a return on equity of 25.89%. The company had revenue of $624.90 million during the quarter, compared to the consensus estimate of $626.04 million. During the same quarter in the prior year, the company earned $5.64 EPS. The business’s quarterly revenue was up 3.1% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is presently 12.69%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.